Now FDA Approved
This post was authored by Jim Burns, Head of North America R&D Hub for Sanofi. For the past twenty years, I’ve been part of an amazing tradition where Sanofi’s scientists come together to share their research and discoveries. This annual event, known as the Science Offsite, brings together scientists from our R&D community across all therapeutic areas and stages of discovery and development.
Sanofi US continues its efforts to complete the return and reimbursement process associated with the October 28, 2015, voluntary nationwide product recall of Auvi-Q® (epinephrine injection, USP).
Last update: September 30, 2016